The Hanmi’s Esomezol has tasted bitterness in the U.S. market, but learned something

Amneal, taking charge of the sale right of the Hanmi Pharm’s reflux esophagitis treatment, Esomezol(esomeprazole strontium), has practically stopped its distribution in a year and a half.

Recently, Amneal made an announcement in its webpage that it will make a suspension of the Esomezol distribution in the U.S.

Esomezol, the improved new drug of the AstraZeneca’s Nexium, was approved for the ...